Indication

Actinomycosis

Actinomycosis is a rare, subacute to chronic, slowly progressive bacterial infection primarily caused by anaerobic or microaerophilic, filamentous, Gram-positive species of the genus *Actinomyces*, most notably *Actinomyces israelii*. Read more about Actinomycosis

237 drugs 118 manufacturers

Advertisement

Drugs that treat it

Common Actinomycosis therapies.

Showing 199–207 of 237 drugs

Filter & compare in the drug finder →Opens the drug finder with Actinomycosis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Actinomycosis.

Actinomycosis is a rare, subacute to chronic, slowly progressive bacterial infection primarily caused by anaerobic or microaerophilic, filamentous, Gram-positive species of the genus *Actinomyces*, most notably *Actinomyces israelii*.

Typically an endogenous infection triggered by mucosal barrier disruption from trauma, dental disease, surgery, or foreign bodies, it most commonly affects the cervicofacial region, though thoracic, abdominopelvic, and central nervous system involvement can also occur.

Pathophysiologically, it is characterized by contiguous tissue invasion that disregards tissue planes, producing indurated granulomatous lesions, extensive fibrosis, multiple abscesses, and draining sinus tracts that classically extrude macroscopic macroscopic bacterial colonies known as sulfur granules.

Personalize your experience

Follow Actinomycosis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it